Identification of a highly conserved surface on Tat variants.
about
Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.Smart nanoparticles as targeting platforms for HIV infections.HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity.
P2860
Identification of a highly conserved surface on Tat variants.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Identification of a highly conserved surface on Tat variants.
@en
type
label
Identification of a highly conserved surface on Tat variants.
@en
prefLabel
Identification of a highly conserved surface on Tat variants.
@en
P2093
P2860
P356
P1476
Identification of a highly conserved surface on Tat variants.
@en
P2093
Albert Darque
Christian Devaux
Erwann P Loret
Gilbert Baillat
Isabelle Ravaux
Sonia Mediouni
P2860
P304
19072-19080
P356
10.1074/JBC.M113.466011
P407
P577
2013-05-15T00:00:00Z